Stay Ahead in Life Sciences Real Estate

Life sciences real estate is a specialised segment expanding at a speed that outpaces most traditional property sectors.

Life science contract organisations balance real estate ownership (73 per cent) vs leasing (27 per cent) based on financial, operational, and strategic considerations.

LABS is exploring options including potential sale or wind-down after facing market challenges, with shares trading at a steep discount to NAV.

Pharmaceutical giants are transforming their real estate strategies. Industry leaders are shifting from traditional property ownership to strategic lease-ownership balancing for financial efficiency and flexibility.

Historic buildings across Europe are being repurposed into modern life sciences facilities, preserving heritage while supporting innovation.

As AI reshapes both biotech and cloud computing, investors are increasingly drawn to these surprisingly similar asset classes.